Herbs that might be effective for the management of COVID-19: A bioinformatics analysis on anti-tyrosine kinase property
Won Sriwijitalai1, Viroj Wiwanitkit2
1 Private Academic Writer/Consultant, Bangkok, Thailand
2 Department of Community Medicine, Dr. DY Patil University, Pune, Maharashtra, India; Department of Tropical Medicine, Hainan Medical University, Haikou, China; Department of Biological Science, Joseph Ayobabalola University, Ikeji-Arakeji, Nigeria
|Date of Submission||28-Mar-2020|
|Date of Decision||04-Apr-2020|
|Date of Acceptance||15-Apr-2020|
|Date of Web Publication||06-May-2020|
Dr. Won Sriwijitalai
RVT Medical Center, Bangkok
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Sriwijitalai W, Wiwanitkit V. Herbs that might be effective for the management of COVID-19: A bioinformatics analysis on anti-tyrosine kinase property. J Res Med Sci 2020;25:44
|How to cite this URL:|
Sriwijitalai W, Wiwanitkit V. Herbs that might be effective for the management of COVID-19: A bioinformatics analysis on anti-tyrosine kinase property. J Res Med Sci [serial online] 2020 [cited 2021 Apr 14];25:44. Available from: https://www.jmsjournal.net/text.asp?2020/25/1/44/283851
COVID-19 is an important new infectious disease that affects >150 countries worldwide. This respiratory infection is a public health emergency to be managed. As a new disease, there is limited knowledge of treatment. In general, many drugs are tests for possible efficacy in disease management. The widely used antiviral drugs include oseltamivir and anti-HIV drugs. In medical science, there are also attempts to find herbs, natural products, which might be effective in the treatment of the coronavirus disease. In the previous report, an important target that is useful for the treatment of coronavirus disease is tyrosine kinase. Any herbs that pose anti-tyrosine kinase property might be useful for the treatment of COVID-19. Here, the authors perform a pharmacoinformatics study to search for herbs that have antipeptidase property and might be useful. Using the same database mining technique as in the referencing publication, the PubMed database is used as a primary tool for data mining. According to data mining, there are at least herbs that present anti-tyrosine kinase properties and might be useful for the treatment of COVID-19. Those herbs are Hesperethusa crenulata,Perilla frutescens,Ephedra equisetina,Shiraia bambusicola,Panax ginseng and Carthamus tinctorius L [Table 1]. Of interest, those herbs are the classical well-known herbs in East Asia, where the COVID-19first emerged. The present data mining is only to roughly include potential herbs for further studies on the possible usefulness in the management of COVID-19. Some of these herbs are already confirmed for their advantages in the management of viral respiratory infections. For example, E. equisetina and P. ginseng are confirmed for its anti-influenza property.,
|Table 1: Local herbs that have potentials for the treatment of coronavirus disease 2019|
Click here to view
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther 2020;14:58-60.
Ling CQ. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2). J Integr Med 2020;18:87-8.
Sisk JM, Frieman MB, Machamer CE. Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors. J Gen Virol 2018;99:619-30.
Wiwanitkit V. Analysis of Mycobacterium leprae
genome: In silico
searching for drug targets. Southeast Asian J Trop Med Public Health 2005;36 Suppl 4:225-7.
Wangthong S, Palaga T, Rengpipat S, Wanichwecharungruang SP, Chanchaisak P, Heinrich M. Biological activities and safety of Thanaka (Hesperethusa crenulata
) stem bark. J Ethnopharmacol 2010;132:466-72.
El-Hafeez AA, Fujimura T, Kamei R, Hirakawa N, Baba K, Ono K, et al
. Synergistic tumor suppression by a Perilla frutescens
-derived methoxyflavanone and anti-cancer tyrosine kinase inhibitors in A549 human lung adenocarcinoma. Cytotechnology 2018;70:913-9.
Hyuga S. The pharmacological actions of ephedrine alkaloids-free ephreda herb extract and preparation for clinical application. Yakugaku Zasshi 2017;137:179-86.
Zhang YX, Chen Y, Guo XN, Zhang XW, Zhao WM, Zhong L, et al
. 11,11'-dideoxy-verticillin: A natural compound possessing growth factor receptor tyrosine kinase-inhibitory effect with anti-tumor activity. Anticancer Drugs 2005;16:515-24.
Sathishkumar N, Karpagam V, Sathiyamoorthy S, Woo MJ, Kim YJ, Yang DC. Computer-aided identification of EGFR tyrosine kinase inhibitors using ginsenosides from Panax ginseng. Comput Biol Med 2013;43:786-97.
Yuk TH, Kang JH, Lee SR, Yuk SW, Lee KG, Song BY, et al
. Inhibitory effect of Carthamus tinctorius
L. seed extracts on bone resorption mediated by tyrosine kinase, COX-2 (cyclooxygenase) and PG (prostaglandin) E2. Am J Chin Med 2002;30:95-108.
Hyuga S, Hyuga M, Oshima N, Maruyama T, Kamakura H, Yamashita T, et al
. Ephedrine alkaloids-free ephedra herb extract: A safer alternative to ephedra with comparable analgesic, anticancer, and anti-influenza activities. J Nat Med 2016;70:571-83.
Scaglione F, Cattaneo G, Alessandria M, Cogo R. Efficacy and safety of the standardised Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold [corrected]. Drugs Exp Clin Res 1996;22:65-72.
|This article has been cited by|
||Bioinformatics Analysis for Screening of Therapeutic Drugs in COVID-19
| ||Pathum Sookaromdee,Viroj Wiwanitkit |
| ||Archives of Medical Research. 2021; |
|[Pubmed] | [DOI]|
||Current status of COVID-19 pandemic; characteristics, diagnosis, prevention, and treatment
| ||Zary Nokhodian,MohammadMehdi Ranjbar,Parto Nasri,Nazila Kassaian,Parisa Shoaei,Bahareh Vakili,Soodabeh Rostami,Shahrzad Ahangarzadeh,Abbas Alibakhshi,Fatemeh Yarian,ShaghayeghHaghjooy Javanmard,Behrooz Ataei |
| ||Journal of Research in Medical Sciences. 2020; 25(1): 101 |
|[Pubmed] | [DOI]|